Calif. voters lean toward stem cell measure-pol
By Reuters,
Reuters
| 09. 24. 2004
LOS ANGELES, Sept 23 (Reuters) - A majority of likely voters in California favor a ballot proposal that would authorize $3 billion in state bonds to fund controversial stem cell research, according to a poll released on Thursday.
The referendum, on the Nov. 2 ballot, would create the largest pool of public funding for such research in the United States at a time when the Bush administration has sharply curtailed spending on studies involving embryonic stem cells.
Backers of the initiative, including Hollywood celebrities and Silicon Valley billionaires, argue that such research could potentially lead to cures for diseases such as Parkinson's, Alzheimer's and diabetes.
A survey by the Los Angeles Times showed that while most voters had not yet formed an opinion on the ballot measure known as Proposition 71, a majority expressed support once they were read the proposal itself.
The survey showed 54 percent of likely voters in California said they were inclined to vote for the stem cell proposal, compared with 32 percent who said they would vote against it.
Fourteen percent said they were not...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...